Study title: Multicentre double-blind group comparative study assess the efficacy of substituting nedocromil sodium (Tilade) 8 mg daily and sodium cromoglycate (Intal) 20 mg daily in paediatric patients currently maintained on sodium cromoglycate 20 mg daily - D. Hilde et al. - 1993 - Publication in Tilade metered-dose inhaler (nedocromil sodium 2 mg) - Clinical expert report for extension of use in children- clinical documentation - K. Rocchiccioli - 24/06/1994 -
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: NEDOCROMIL | |||||
ATC code: S01GX04 | |||||
Document link: | |||||
Document date: 2013-01-24 | |||||
Study number: CR 2202 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |